Total Payments
$4,856
2024 Payments
$626.74
Companies
19
Transactions
235
Medicare Patients
939
Medicare Billing
$66,723
Payment Breakdown by Category
Food & Beverage$4,761 (98.0%)
Education$94.99 (2.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,761 | 234 | 98.0% |
| Education | $94.99 | 1 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $1,069 | 48 | $0 (2024) |
| GlaxoSmithKline, LLC. | $633.11 | 32 | $0 (2024) |
| ABBVIE INC. | $580.34 | 30 | $0 (2024) |
| Astellas Pharma US Inc | $423.65 | 18 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $421.95 | 17 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $356.66 | 17 | $0 (2024) |
| Novo Nordisk Inc | $319.61 | 26 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $269.86 | 9 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $195.39 | 4 | $0 (2023) |
| PFIZER INC. | $156.81 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $626.74 | 31 | ABBVIE INC. ($223.40) |
| 2023 | $1,501 | 59 | GlaxoSmithKline, LLC. ($312.96) |
| 2022 | $1,847 | 97 | Lilly USA, LLC ($436.43) |
| 2021 | $881.12 | 48 | Biohaven Pharmaceuticals, Inc. ($269.86) |
All Payment Transactions
235 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.32 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | SANOFI PASTEUR INC. | BEYFORTUS (Biological) | Food and Beverage | In-kind items and services | $23.57 | General |
| Category: Vaccines | ||||||
| 10/17/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: Diabetes | ||||||
| 10/03/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: PAIN | ||||||
| 09/24/2024 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO, ZEPBOUND | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: Diabetes | ||||||
| 09/22/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: Biological | ||||||
| 09/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: DIABETES | ||||||
| 08/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: Diabetes | ||||||
| 08/15/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: Diabetes | ||||||
| 08/08/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $27.02 | General |
| Category: NEUROSCIENCE | ||||||
| 08/01/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: PAIN | ||||||
| 07/11/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: NEUROSCIENCE | ||||||
| 06/27/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: Diabetes | ||||||
| 06/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: Diabetes | ||||||
| 06/18/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $25.65 | General |
| Category: NEUROSCIENCE | ||||||
| 06/12/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: Biological | ||||||
| 06/06/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $25.72 | General |
| Category: NEUROSCIENCE | ||||||
| 05/09/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $23.04 | General |
| Category: NEUROSCIENCE | ||||||
| 05/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $25.16 | General |
| Category: RESPIRATORY | ||||||
| 04/15/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: NEUROSCIENCE | ||||||
| 04/07/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: Biological | ||||||
| 03/28/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 280 | 345 | $74,198 | $16,430 |
| 2022 | 5 | 280 | 386 | $90,322 | $21,283 |
| 2021 | 7 | 303 | 394 | $52,964 | $24,027 |
| 2020 | 2 | 76 | 78 | $12,375 | $4,983 |
Total Patients
939
Total Services
1,203
Medicare Billing
$66,723
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 111 | 148 | $36,260 | $7,290 | 20.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 65 | 82 | $28,290 | $6,728 | 23.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 19 | 21 | $5,145 | $1,111 | 21.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 19 | 20 | $3,080 | $714.37 | 23.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 40 | 44 | $572.00 | $369.60 | 64.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 15 | 19 | $741.00 | $180.20 | 24.3% |
| 81002 | Urinalysis, manual test | Office | 2023 | 11 | 11 | $110.00 | $37.51 | 34.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 122 | 182 | $44,590 | $10,787 | 24.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 68 | 91 | $31,395 | $6,690 | 21.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 42 | 53 | $12,985 | $3,456 | 26.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 15 | 22 | $858.00 | $238.92 | 27.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 33 | 38 | $494.00 | $112.26 | 22.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 104 | 143 | $27,885 | $12,107 | 43.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 96 | 138 | $18,216 | $7,550 | 41.4% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 40 | 46 | $3,956 | $2,701 | 68.3% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 12 | 14 | $1,736 | $1,394 | 80.3% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 12 | 14 | $700.00 | $151.48 | 21.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 27 | 27 | $351.00 | $81.00 | 23.1% |
| 81002 | Urinalysis, manual test | Office | 2021 | 12 | 12 | $120.00 | $41.76 | 34.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 43 | 45 | $5,940 | $2,528 | 42.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 33 | 33 | $6,435 | $2,454 | 38.1% |
About Samantha Jacinto
Samantha Jacinto is a Physician Assistant healthcare provider based in Sacramento, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/21/2019. The National Provider Identifier (NPI) number assigned to this provider is 1932760857.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Samantha Jacinto has received a total of $4,856 in payments from pharmaceutical and medical device companies, with $626.74 received in 2024. These payments were reported across 235 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($4,761).
As a Medicare-enrolled provider, Jacinto has provided services to 939 Medicare beneficiaries, totaling 1,203 services with total Medicare billing of $66,723. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Sacramento, CA
- Active Since 06/21/2019
- Last Updated 06/14/2021
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1932760857
Products in Payments
- NURTEC ODT (Drug) $734.28
- TRELEGY ELLIPTA (Drug) $501.32
- MOUNJARO (Drug) $460.89
- TRULICITY (Drug) $345.03
- JARDIANCE (Drug) $309.32
- QULIPTA (Drug) $276.87
- EMGALITY (Drug) $250.93
- UBRELVY (Drug) $229.21
- FARXIGA (Drug) $195.39
- Rybelsus (Drug) $175.08
- Myrbetriq (Drug) $153.20
- Veozah (Drug) $141.43
- TRINTELLIX (Drug) $139.55
- Ozempic (Drug) $113.60
- AREXVY (Drug) $84.17
- VRAYLAR (Drug) $74.26
- Kerendia (Drug) $70.46
- Otezla (Drug) $63.74
- ENTRESTO (Drug) $50.37
- COMIRNATY (Biological) $45.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Sacramento
Mr. Franklin Cline, Pa-C, PA-C
Physician Assistant — Payments: $346,059
Physician Assistant $346,059
Mr. Antonio Luza, Pa-C, PA-C
Physician Assistant — Payments: $19,162
Physician Assistant $19,162
Mr. Joseph Karpel, Pa-C, Mph, PA-C, MPH
Physician Assistant — Payments: $12,480
Physician Assistant $12,480
Alexa Herzig
Physician Assistant — Payments: $10,684
Physician Assistant $10,684
Ms. Sandra Kemptner, Pa-C, PA-C
Physician Assistant — Payments: $10,567
Physician Assistant $10,567
Glenn Quijano, Pa-C, PA-C
Physician Assistant — Payments: $9,852
Physician Assistant $9,852